<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pulmonary metastasectomy is undertaken for a range of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The questions we raise here are specifically related to <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, the commonest <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> for which pulmonary metastasectomy is undertaken </plain></SENT>
<SENT sid="2" pm="."><plain>The primary objective of metastasectomy is to increase survival </plain></SENT>
<SENT sid="3" pm="."><plain>There are no randomised trials in support of this practice nor are there any other forms of controlled studies </plain></SENT>
<SENT sid="4" pm="."><plain>We present a critical look at the assumption of efficacy for this surgery and propose that a trial is needed and suggest a trial design </plain></SENT>
</text></document>